Back to Results
First PageMeta Content
Medicine / Connective tissue diseases / Cutaneous lupus erythematosus / Systemic lupus erythematosus / Autoantibodies / Syndromes / Rheumatoid arthritis / Autoimmunity / Anti-SSA/Ro autoantibodies / Anatomy / Health / Autoimmune diseases


Available online http://arthritis-research.com/content[removed]Editorial How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?
Add to Reading List

Open Document

File Size: 43,21 KB

Share Result on Facebook

City

Charleston / Baltimore / /

Company

BioMed Central Ltd / /

Country

United States / Spain / /

/

Facility

Medical University of South Carolina / /

IndustryTerm

antigen processing / treatment of rheumatic diseases / /

MedicalCondition

systemic lupus erythematosus / disease / Mycobacterium tuberculosis / infectious complications / SLE-associated dysfunction / rheumatoid arthritis / rheumatic diseases / serious infections / active disease / milder disease / latent infections / infectious pathogens / altered infection / infection / SLE / Lupus / infections / influenza / serious infection / /

MedicalTreatment

immunization / immunosuppression / vaccinations / vaccination / drug therapy / /

Organization

Medical University of South Carolina / European Working Party on Systemic Lupus Erythematosus / Kamen Division of Rheumatology / /

Person

Diane L Kamen / Ann Rheum Dis / Ann Rheum / Van Riel / /

Position

author / Singer / Corresponding author / /

Product

prednisone / /

ProvinceOrState

South Carolina / /

RadioStation

Bertoli AM / /

URL

http /

SocialTag